Skip to main content
SpringerLink
Log in

Use of Imaging Techniques to Screen Hepatocellular Carcinoma

  • Chapter
  • First Online:
Book cover Hepatocellular Carcinoma

Part of the book series: Current Clinical Oncology ((CCO))

  • 2029 Accesses

Abstract

This chapter is intended to provide a state-of-the art overview of liver imaging with emphasis on the roles of sonography, CT, and MRI in the cirrhotic patient. Fundamentals of using imaging in a surveillance program to monitor the progression of cirrhosis and to detect hepatocellular carcinoma (HCC) are included. Imaging features are discussed that are useful in distinguishing among the various focal lesions that may be found in the cirrhotic liver, including regenerative, dysplastic, and malignant nodules.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Miller WJ, Campbell WL, et al. Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology. 1993;188(1):31–5.

    Article  CAS  PubMed  Google Scholar 

  2. Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Ohtomo Y, Confer SR. Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology. 1993;189(3):871–4.

    Article  CAS  PubMed  Google Scholar 

  3. Ozaki K, Matsui O, Gabata T, Kobayashi S, Koda W, Minami T. Confluent hepatic fibrosis in liver cirrhosis: possible relation with middle hepatic venous drainage. Jpn J Radiol. 2013;31(8):530–7.

    Article  PubMed  Google Scholar 

  4. Murakami T, Nakamura H, Hori S, Nakanishi K, Mitani T, Tsuda K, et al. CT and MRI of siderotic regenerating nodules in hepatic cirrhosis. J Comput Assist Tomogr. 1992;16(4):578–82.

    Article  CAS  PubMed  Google Scholar 

  5. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991;22(2):172–8.

    Article  CAS  PubMed  Google Scholar 

  6. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 1990;336(8724):1150–3.

    Article  CAS  PubMed  Google Scholar 

  7. International Working P. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22(3):983–93.

    Google Scholar 

  8. Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis: part II, focal abnormalities. AJR Am J Roentgenol. 1999;173(5):1185–92.

    Article  PubMed  Google Scholar 

  9. Krinsky GA, Lee VS, Theise ND, Weinreb JC, Rofsky NM, Diflo T, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology. 2001;219(2):445–54.

    Article  CAS  PubMed  Google Scholar 

  10. Lim JH, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, et al. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol. 2000;175(3):693–8.

    Article  CAS  PubMed  Google Scholar 

  11. Kobayashi M, Ikeda K, Hosaka T, Sezaki H, Someya T, Akuta N, et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer. 2006;106(3):636–47.

    Article  PubMed  Google Scholar 

  12. Tanaka S, Kitamra T, Fujita M, Kasugai H, Inoue A, Ishiguro S. Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. Radiology. 1992;182(1):161–5.

    Article  CAS  PubMed  Google Scholar 

  13. Kudo M, Hatanaka K, Inoue T, Maekawa K. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma. Oncology. 2010;78(Suppl 1):60–7.

    Article  PubMed  Google Scholar 

  14. Bennett GL, Krinsky GA, Abitbol RJ, Kim SY, Theise ND, Teperman LW. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol. 2002;179(1):75–80.

    Article  PubMed  Google Scholar 

  15. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Takashima T, Nakanuma Y, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178(2):493–7.

    Article  CAS  PubMed  Google Scholar 

  16. Ebara M, Ohto M, Watanabe Y, Kimura K, Saisho H, Tsuchiya Y, et al. Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies. Radiology. 1986;159(2):371–7.

    Article  CAS  PubMed  Google Scholar 

  17. Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, Matsuda M, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology. 2011;261(3):834–44.

    Article  PubMed  Google Scholar 

  18. Bartolotta TV, Taibbi A, Midiri M, Matranga D, Solbiati L, Lagalla R. Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography. Invest Radiol. 2011;46(2):106–15.

    Article  PubMed  Google Scholar 

  19. Inoue T, Kudo M, Maenishi O, Komuta M, Nakashima O, Kojiro M, et al. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma. AJR Am J Roentgenol. 2009;192(3):698–705.

    Article  PubMed  Google Scholar 

  20. Goshima S, Kanematsu M, Kondo H, Shiratori Y, Onozuka M, Moriyama N, et al. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma. AJR Am J Roentgenol. 2009;192(3):686–92.

    Article  PubMed  Google Scholar 

  21. Brancatelli G, Federle MP, Blachar A, Grazioli L. Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology. 2001;219(1):69–74.

    Article  CAS  PubMed  Google Scholar 

  22. Kim T, Federle MP, Baron RL, Peterson MS, Kawamori Y. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology. 2001;219(3):699–706.

    Article  CAS  PubMed  Google Scholar 

  23. Murakami T, Mochizuki K, Nakamura H. Imaging evaluation of the cirrhotic liver. Semin Liver Dis. 2001;21(2):213–24.

    Article  CAS  PubMed  Google Scholar 

  24. Mori K, Yoshioka H, Itai Y, Okamoto Y, Mori H, Takahashi N, et al. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR Am J Roentgenol. 2000;175(6):1659–64.

    Article  CAS  PubMed  Google Scholar 

  25. Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology. 2001;218(3):763–7.

    Article  CAS  PubMed  Google Scholar 

  26. Itai Y, Matsui O. Blood flow and liver imaging. Radiology. 1997;202(2):306–14.

    Article  CAS  PubMed  Google Scholar 

  27. Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS. Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology. 2000;217(3):750–6.

    Article  CAS  PubMed  Google Scholar 

  28. Inaba Y, Itai Y, Arai Y, Matsueda K, Yamagami T, Sueyoshi S, et al. Focal attenuation differences in pericystic liver tissue as seen on CT hepatic arteriography and CT arterial portography: observation using a unified helical CT and angiography system. Abdom Imaging. 1999;24(4):360–5.

    Article  CAS  PubMed  Google Scholar 

  29. Yamagami T, Arai Y, Matsueda K, Inaba Y, Sueyoshi S, Takeuchi Y. The cause of nontumorous defects of portal perfusion in the hepatic hilum revealed by CT during arterial portography. AJR Am J Roentgenol. 1999;172(2):397–402.

    Article  CAS  PubMed  Google Scholar 

  30. Kanematsu M, Kondo H, Enya M, Yokoyama R, Hoshi H. Nondiseased portal perfusion defects adjacent to the right ribs shown on helical CT during arterial portography. AJR Am J Roentgenol. 1998;171(2):445–8.

    Article  CAS  PubMed  Google Scholar 

  31. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology. 1992;183(3):819–25.

    Article  CAS  PubMed  Google Scholar 

  32. Beavers KL, Semelka RC. MRI evaluation of the liver. Semin Liver Dis. 2001;21(2):161–77.

    Article  CAS  PubMed  Google Scholar 

  33. Muhler A, Clement O, Saeed M, Lake JR, Stites DP, Berthezene Y, et al. Gadolinium-ethoxybenzyl-DTPA, a new liver-directed magnetic resonance contrast agent. Absence of acute hepatotoxic, cardiovascular, or immunogenic effects. Invest Radiol. 1993;28(1):26–32.

    Article  CAS  PubMed  Google Scholar 

  34. Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T. Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol. 2004;39(2):80–8.

    Article  PubMed  Google Scholar 

  35. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology. 2009;49(2):658–64.

    Article  Google Scholar 

  36. Addley HC, Griffin N, Shaw AS, Mannelli L, Parker RA, Aitken S, et al. Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol. 2011;66(4):349–56.

    Article  CAS  PubMed  Google Scholar 

  37. Kakihara D, Nishie A, Harada N, Shirabe K, Tajima T, Asayama Y, et al. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography. J Magn Reson Imaging. 2014;40(5):1112–20.

    Article  PubMed  Google Scholar 

  38. Arii S, Tobe T. Results of surgical treatment. Follow-up study by liver cancer study group of Japan. In: Tobe T, et al. editors. Primary liver cancer in Japan. Tokyo: Springer; 1992.

    Google Scholar 

  39. Achkar JP, Araya V, Baron RL, Marsh JW, Dvorchik I, Rakela J. Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation. Liver Transpl Surg. 1998;4(6):477–82.

    Article  CAS  PubMed  Google Scholar 

  40. Mor E, Tur-Kaspa R, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med. 1998;129(8):643–53.

    Article  CAS  PubMed  Google Scholar 

  41. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the liver. J Hepatol. 2001;35(3):421–30.

    Article  CAS  PubMed  Google Scholar 

  42. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology. 1998;27(1):273–8.

    Article  CAS  PubMed  Google Scholar 

  43. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology. 1986;6(4):729–38.

    Article  CAS  PubMed  Google Scholar 

  44. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology. 1992;16(1):132–7.

    Article  CAS  PubMed  Google Scholar 

  45. Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology. 1986;90(2):289–98.

    Article  CAS  PubMed  Google Scholar 

  46. Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y, et al. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the liver cancer study group of Japan: 2014 update. Oncology. 2014;87(Suppl 1):7–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Gifu University Hospital, Gifu, Japan

    Satoshi Goshima

Authors
  1. Satoshi Goshima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satoshi Goshima .

Editor information

Editors and Affiliations

  1. Dokuz Eylul University, Izmir Biomedicine and Genome Center Dokuz Eylul University, Izmir, Izmir, Turkey

    Brian I. Carr

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Goshima, S. (2016). Use of Imaging Techniques to Screen Hepatocellular Carcinoma. In: Carr, B. (eds) Hepatocellular Carcinoma. Current Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-34214-6_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34214-6_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34212-2

  • Online ISBN: 978-3-319-34214-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation